Search Results - "LUEDTKE DANIEL A" :: K.UTB vyhledávací portál

Inhibition of XPO1 enhances cell death induced by ABT‐199 in acute myeloid leukaemia via Mcl‐1

by Luedtke, Daniel A., Su, Yongwei, Liu, Shuang, Edwards, Holly, Wang, Yue, Lin, Hai, Taub, Jeffrey W., Ge, Yubin
Published in Journal of cellular and molecular medicine (01.12.2018)

Get full text

Journal Article

Loading…

Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells

by Ma, Jun, Li, Xinyu, Su, Yongwei, Zhao, Jianyun, Luedtke, Daniel A., Epshteyn, Valeria, Edwards, Holly, Wang, Guan, Wang, Zhihong, Chu, Roland, Taub, Jeffrey W., Lin, Hai, Wang, Yue, Ge, Yubin
Published in Scientific reports (08.02.2017)

Get full text

Journal Article

Loading…

Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells

by Luedtke, Daniel A, Niu, Xiaojia, Pan, Yihang, Zhao, Jianyun, Liu, Shuang, Edwards, Holly, Chen, Kang, Lin, Hai, Taub, Jeffrey W, Ge, Yubin
Published in Signal transduction and targeted therapy (01.01.2017)

Get full text

Journal Article

Loading…

Inhibition of XPO 1 enhances cell death induced by ABT ‐199 in acute myeloid leukaemia via Mcl‐1

by Luedtke, Daniel A., Su, Yongwei, Liu, Shuang, Edwards, Holly, Wang, Yue, Lin, Hai, Taub, Jeffrey W., Ge, Yubin
Published in Journal of cellular and molecular medicine (01.12.2018)

Get full text

Journal Article

Loading…

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia

by Luedtke, Daniel A., Su, Yongwei, Ma, Jun, Li, Xinyu, Buck, Steven A., Edwards, Holly, Polin, Lisa, Kushner, Juiwanna, Dzinic, Sijana H., White, Kathryn, Lin, Hai, Taub, Jeffrey W., Ge, Yubin
Published in Signal transduction and targeted therapy (26.02.2020)

Get full text

Journal Article

Loading…

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia

by Luedtke, Daniel A, Su, Yongwei, Ma, Jun, Li, Xinyu, Buck, Steven A, Edwards, Holly, Polin, Lisa, Kushner, Juiwanna, Dzinic, Sijana H, White, Kathryn, Lin, Hai, Taub, Jeffrey W, Ge, Yubin
Published in Signal transduction and targeted therapy (26.02.2020)

Get full text

Journal Article

Loading…

Inhibition of Both IRAK1 and IRAK4 Is Required for Complete Suppression of NF-Kb Signaling across Multiple Receptor-Mediated Pathways in MDS and AML

by Rosenbaum, Jan S, Hoyt, Scott B., Kolt, Amal S., Luedtke, Daniel A, Thomas, Craig J., Starczynowski, Daniel T.
Published in Blood (15.11.2022)

Get full text

Journal Article

Loading…

Inhibition of XPO1 By KPT-330 (Selinexor) Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor ABT-199 (Venetoclax) through Downregulation of Mcl-1 in Acute Myeloid Leukemia

by Luedtke, Daniel A, Su, Yongwei, Edwards, Holly, Lin, Hai, Taub, Jeffrey W., Ge, Yubin
Published in Blood (08.12.2017)

Get full text

Journal Article

Loading…

Voruciclib, an Oral, Selective CDK9 Inhibitor, Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor Venetoclax in Acute Myeloid Leukemia

by Luedtke, Daniel A, Su, Yongwei, Edwards, Holly, Polin, Lisa, Kushner, Juiwanna, Dzinic, Sijana H, Lin, Hai, Taub, Jeffrey W., Ge, Yubin
Published in Blood (29.11.2018)

Get full text

Journal Article